ACCC in partnership with organizations across the cancer care community have issued a consensus statement identifying the primary drivers behind persistent shortages of critical cancer medications—and, importantly, outlining actionable policy solutions to help ensure patients receive the care they need, when they need it. Read the full statement.
January 21, 2026
October 30, 2025
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
